• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

器官获取与移植网络/美国器官共享联合网络肝脏移植登记处分析。

An analysis of the OPTN/UNOS Liver Transplant Registry.

作者信息

Waki Kayo, Tamura Sumihito, Sugawara Yasuhiko, Yamashiki Noriyo, Kadowaki Takashi, Kokudo Norihiro

机构信息

Terasaki Foundation Laboratory, Los Angeles, California, USA.

出版信息

Clin Transpl. 2009:55-64.

PMID:20524276
Abstract

This chapter summarizes analyses of 51,060 adult primary liver-only transplants from deceased donors reported to the OPTN/UNOS Liver Transplant Registry from 1995 to 2009. Despite advances in surgical techniques and immunosuppression, analysis shows improvement in one-year graft but no improvement in long-term graft survival. Adoption of the Model for End-Stage Liver Disease (MELD) score for organ allocation--prioritizing sicker patients for transplantation--has significantly influenced liver transplant procedures. Accordingly, we classified the transplants into two groups: 1995-2001 (pre-MELD era) and 2002-2007 (MELD era), and our analyses found that long-term survival of liver grafts remained almost unchanged between the two eras. Patient pre-transplant status was better in the MELD era. But when we analyzed the grafts that survived more than one year, survival rates were slightly better pre-MELD than in the MELD era (82.2% and 80.34%, respectively) and risk of graft failure was slightly higher in the MELD era. This chapter also provides analyses of current graft survival rates for 10 different primary liver diseases. Hepatocellular carcinoma, hepatitis C virus cirrhosis, and alcoholic liver disease account for almost 50 % of the primary diseases, and have worse graft survival than the other primary diseases. The lack of improvement in long-term survival suggests an on-going need for means to avoid chronic liver graft dysfunction and to develop therapeutic interventions to control chronic graft loss.

摘要

本章总结了1995年至2009年向器官获取与移植网络/器官共享联合系统肝脏移植登记处报告的51,060例来自已故供体的成人单纯肝移植分析。尽管手术技术和免疫抑制有所进步,但分析显示一年期移植物有改善,但长期移植物存活率没有提高。采用终末期肝病模型(MELD)评分进行器官分配——优先考虑病情较重的患者进行移植——对肝移植程序产生了重大影响。因此,我们将移植分为两组:1995 - 2001年(MELD时代之前)和2002 - 2007年(MELD时代),我们的分析发现两个时代之间肝移植物的长期存活率几乎没有变化。MELD时代患者移植前状况更好。但当我们分析存活超过一年的移植物时,MELD时代之前的存活率略高于MELD时代(分别为82.2%和80.34%),且MELD时代移植物失败风险略高。本章还提供了10种不同原发性肝病当前移植物存活率的分析。肝细胞癌、丙型肝炎病毒肝硬化和酒精性肝病占原发性疾病的近50%,且移植物存活率比其他原发性疾病更差。长期存活率缺乏改善表明持续需要采取措施避免慢性肝移植物功能障碍,并开发治疗干预措施来控制慢性移植物丢失。

相似文献

1
An analysis of the OPTN/UNOS Liver Transplant Registry.器官获取与移植网络/美国器官共享联合网络肝脏移植登记处分析。
Clin Transpl. 2009:55-64.
2
Liver transplantation in the United States.美国的肝脏移植
Clin Transpl. 2005:17-28.
3
UNOS Liver Registry: ten year survivals.器官共享联合网络肝脏登记处:十年生存率
Clin Transpl. 2006:29-39.
4
Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.终末期肝病模型(MELD)时代的肝移植——器官获取与移植网络(OPTN)/美国器官共享联合网络(UNOS)登记处分析
Clin Transpl. 2012:41-65.
5
An analysis of the OPTN/UNOS Liver Transplant Registry.器官获取与移植网络/美国器官共享联合网络肝脏移植登记处分析。
Clin Transpl. 2004:315-29.
6
A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.终末期肝病模型(MELD)时代之前与之后肝移植结果的比较。
Aliment Pharmacol Ther. 2005 Jan 15;21(2):169-77. doi: 10.1111/j.1365-2036.2005.02321.x.
7
The OPTN/UNOS Renal Transplant Registry.器官获取与移植网络/美国器官共享联合网络肾脏移植登记处
Clin Transpl. 2005:1-16.
8
Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts.终末期肝病模型(MELD)时代肝肾联合移植的疗效下降:肾移植受者的无效使用
Transplantation. 2008 Apr 15;85(7):935-42. doi: 10.1097/TP.0b013e318168476d.
9
MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.肝移植后预测短期死亡率的MELD评分与传统的器官共享联合网络(UNOS)状态对比
Transpl Int. 2005 Jan;18(1):65-72. doi: 10.1111/j.1432-2277.2004.00024.x.
10
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients.终末期肝病模型(MELD)评分作为器官获取与移植网络(OPTN)/美国器官共享联合网络(UNOS)1级患者移植前和移植后生存情况的预测指标
Hepatology. 2004 Mar;39(3):764-9. doi: 10.1002/hep.20083.

引用本文的文献

1
Pentoxifylline Plus Prednisolone versus Pentoxifylline Only for Severe Alcoholic Hepatitis: A Randomized Controlled Clinical Trial.己酮可可碱联合泼尼松龙与单用己酮可可碱治疗重度酒精性肝炎的随机对照临床试验
Ann Med Health Sci Res. 2014 Sep;4(5):810-6. doi: 10.4103/2141-9248.141562.
2
Alcoholic liver disease: treatment.酒精性肝病:治疗
World J Gastroenterol. 2014 Sep 28;20(36):12934-44. doi: 10.3748/wjg.v20.i36.12934.
3
KASL clinical practice guidelines: management of alcoholic liver disease.KASL临床实践指南:酒精性肝病的管理
Clin Mol Hepatol. 2013 Sep;19(3):216-54. doi: 10.3350/cmh.2013.19.3.216. Epub 2013 Sep 30.